CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 79,600 shares (grant or award)
- 4 Grant or award Director acquired 73,600 shares (grant or award)
- 4 Grant or award Director acquired 96,000 shares (grant or award)
- 4 Grant or award Director acquired 70,000 shares (grant or award)
- 4 Grant or award Director acquired 79,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 685 shares at $1.46 ($1,000)
- 4 Open-market buy President and CEO bought 694 shares at $1.44 ($999)
- 4 Open-market buy President and CEO bought 719 shares at $1.39 ($999)
- 4 Option exercise 10% owner acquired 1,941,770 shares (option exercise)
- 4 Option exercise 10% owner acquired 773,003 shares (option exercise)
- 4 Option exercise 10% owner acquired 583,333 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 768 shares at $1.30 ($998)
- 4 Open-market buy President and CEO bought 555 shares at $1.80 ($999)
- 4 Derivatives Options or other derivatives
Page 13 of 28 · 551 filings